Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

J&J's Alza spins off drug delivery company Macroflux

Executive Summary

J&J's Alza division is spinning out Macroflux Corp., a transdermal drug development company. Macroflux has raised $75mm with a financing led by Nomura Phase4 Ventures with fellow participants New Enterprise Associates, and funds managed by HBM Partners.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Spin-Off

Related Companies

UsernamePublicRestriction

Register